Aster DM Healthcare has announced that its Board of Directors will meet on Thursday, March 26, 2026, to evaluate and approve the declaration of an interim dividend for the Financial Year 2025-26. If approved, the specified record date for the payment of this dividend has been fixed as Friday, April 3, 2026. Separately, the trading window remains closed following the insider trading guidelines until 48 hours after the forthcoming financial results.
Board Meeting for Dividend Approval
Aster DM Healthcare Limited has formally notified the stock exchanges regarding a scheduled meeting of its Board of Directors. The meeting is set to take place on Thursday, March 26, 2026. The primary agenda item for this session is to consider and potentially approve the declaration of an interim dividend for the ongoing Financial Year 2025-26.
Record Date Fixed
In anticipation of the potential dividend approval, the company has simultaneously established the necessary timeline for shareholders. The record date for determining the eligibility of shareholders for the payment of this interim dividend, should it be declared, is set for Friday, April 3, 2026.
Trading Window Closure Update
Furthermore, the company referenced its prior communication, issued on March 19, 2026, concerning the closure of the trading window for designated persons. In line with the code of conduct for preventing Insider Trading, the window will remain closed until a period of 48 hours has elapsed following the public announcement of the Company’s financial results for the quarter and year ended March 31, 2026.
Source: BSE
